Searched for
SUN PHARMA CHAIRMAN
Stocks in news: Sun Pharma, Tech Mahindra, Tata Motors, Voltas, ONGCIndian markets saw a dip on Friday, with IT stocks leading the decline. Analysts suggest profit-taking occurred near the 24,150 mark. Despi...- SBI in $1 billion funding for Sun Pharma’s US dealState Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....
- Sun Pharma sees steady FY27 growth, progresses $11.75 bn Organon integration dealSun Pharma anticipates strong growth in the coming years. The company expects a high single-digit increase in its overall sales by FY2027. ...
- Ram Shriram's Sherpalo Ventures to lead $60 million funding round in Skyroot; valuation hits $1.1 billionGIC, of Singapore, BlackRock, Greenko Group founders take part in round along with Sun Pharma founder Dilip Shanghvi family office as the 9...
- Sun Pharma to acquire Organon for $11.75 billion in India’s biggest pharma dealSun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...
- Sun Pharma shares jump over 9% after firm announces $12 billion Organon acquisitionSun Pharmaceutical Industries' shares surged after announcing the $11.75 billion acquisition of US-based Organon & Co., a global leader in ...
- ET Exclusive | Sun Pharma set to acquire Organon for $12.5 bn, its biggest till dateUS company’s board meeting is happening this weekend to finalise decision; an announcement is imminent later tonight or by Monday. Mumbai H...
- Stocks in news: RIL, IDFC First Bank, Paytm, Sun Pharma, Manappuram FinanceIndian markets faced pressure extending a corrective phase. Key companies like RIL, IDFC First Bank, and Paytm reported their financial res...
- Sun Pharma looks to outshine rival bids with $13 billion Organon offerSun Pharmaceutical is making its biggest move yet with a $13 billion offer for Organon & Co. This ambitious bid aims to transform the India...
- Sun Pharma closes in on Organon buy, gets set for $12 billion binding bidSun Pharmaceutical Industries is nearing a $12 billion acquisition of Organon & Co, marking its most significant overseas expansion. Follow...
- Sun Pharma appoints Kirti Ganorkar as MD; Dilip Shanghvi to continue as the Executive Chairman of the BoardSun Pharmaceutical Industries has appointed Kirti Ganorkar as Managing Director, succeeding Dilip Shanghvi, effective September 1. Shanghvi...
- Sun Pharma's Chairman Israel Makov to retire after AGM on Aug 29Israel Makov, who led the drug major for 10 years, will step down from the post after the company's Annual General Meeting. He was appointe...
- Sun Pharma chairman calls for more Indo-Israel collaborationIsrael is trying to create such opportunities across the world so that India can tap the knowledge the country has to offer and Israel can ...
- Sun Pharma to buy Ranbaxy in $3.2 bn deal“This is the biggest deal we have done, but not the most difficult one,” said Sun Pharma chairman Dilip Shanghvi.
- Sun Pharma buys controlling stake in Taro, shares upSun Pharmaceuticals today said it has acquired a controlling stake in Israeli pharma major Taro Pharmaceuticals.
- As valuations dip, Sun Pharma is in M&A modeBe it the slowdown of 2001, or that of 2008, good pharma companies in India have continued to grow well with historically high margins, acc...
- Sun offers Taro higher price to settle rowSun Pharmaceuticals on Monday said that it has written to Taro Pharmaceuticals to reach a settlement with the management on taking a majori...
- Sun Pharma writes to Taro for settlementSun Pharmaceuticals on Monday said it has written to Taro Pharmaceuticals to reach a settlement with the management of Taro on taking major...
- Sun shines over Taro: Israeli court clears decks for takeoverSun Pharmaceuticals has won the first round in the legal battle for Taro Pharma, with the Tel-Aviv district court asking promoters of the I...
- Sun Pharma threatens to take legal action against TaroSun Pharma today threatened to take legal action against Israel-based Taro Pharmaceuticals, which terminated the 454-million-dollars merger...
Load More
